₹717.4
▼ -0.86 -0.12%
17 Jul 2026
NSE Listed
Aarti Pharmalabs Limited (AARTIPHARM)
Volume: 1,20,690Avg Vol 1W: 1,49,827Avg Vol 1M: 1,80,031.2552W Range:₹585₹971
Key Ratios
Checked 2h agoMarket Cap₹6,505 Cr
Current Price₹717.4
Previous Close₹718.26
High / Low (52w)₹971 / ₹585
Volume1,20,690
Avg Vol (1W)1,49,827
Avg Vol (1M)1,80,031.25
Stock P/E106.44
Book Value₹234.3
Dividend Yield49%
ROE8.22%
ROA5.36%
Revenue (TTM)₹2,125 Cr
Revenue Growth14.2%
Profit Margin10.25%
Total Debt₹104 Cr
Shares Outstanding9 Cr
Face Value₹5
EPS (TTM)₹19.5
P/B3.06
Debt / Equity0.19
50 DMA₹679.71
200 DMA₹723.23
Day change-0.12%
Price Chart
₹717.4▼ 25.11% · 1Y
2025-07-172026-07-16
20-day avg volume: 1.8L shares
Pros
- Pays a dividend yield of 49.0%.
- Company is almost debt-free.
Cons
- Company is loss-making at the latest annual result.
- Stock trades at a high P/E of 106.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹555 Cr | ₹458 Cr | ₹538 Cr | ₹564 Cr | ₹386 Cr | ₹418 Cr | ₹432 Cr | ₹583 Cr |
| EBITDA | ₹79 Cr | ₹77 Cr | ₹111 Cr | ₹121 Cr | ₹74 Cr | ₹50 Cr | ₹73 Cr | ₹93 Cr |
| Net Profit | ₹55 Cr | ₹55 Cr | ₹74 Cr | ₹88 Cr | ₹50 Cr | ₹28 Cr | ₹48 Cr | ₹61 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹1,202 Cr | ₹1,948 Cr | ₹1,858 Cr | ₹2,125 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹167 Cr | ₹282 Cr | ₹318 Cr | ₹388 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹122 Cr | ₹193 Cr | ₹217 Cr | ₹272 Cr |
| EPS | -0.75 | -0.18 | 13.49 | 21.35 | 23.93 | 30.04 |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Total Assets | ₹0 Cr | ₹0 Cr | ₹2,040 Cr | ₹2,244 Cr | ₹2,582 Cr | ₹2,906 Cr |
| Total Liabilities | ₹0 Cr | ₹0 Cr | ₹653 Cr | ₹686 Cr | ₹825 Cr | ₹917 Cr |
| Equity | ₹0 Cr | ₹0 Cr | ₹1,386 Cr | ₹1,558 Cr | ₹1,757 Cr | ₹1,990 Cr |
| Total Debt | ₹0 Cr | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹0 Cr | ₹-23 Cr | ₹312 Cr | ₹273 Cr | ₹396 Cr |
| Investing | ₹0 Cr | ₹-139 Cr | ₹-158 Cr | ₹-215 Cr | ₹-414 Cr |
| Financing | ₹0 Cr | ₹260 Cr | ₹-163 Cr | ₹10 Cr | ₹65 Cr |
| Free Cash Flow | ₹0 Cr | ₹-23 Cr | ₹313 Cr | ₹273 Cr | ₹396 Cr |
Shareholding
Promoter 43.08% Institutions 15.8% Public 41.12%
Efficiency & Working Capital
ROCE9.6%
Interest Coverage14.4
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details
As of 2026-03-31
Promoter43.1%
FII8.4%
DII7.4%
Institutions15.8%
Public41.1%
Promoter Pledge11%
No. of Shareholders1,79,373
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 46% | 46.3% | 46.5% | 46.5% | 46.5% | 46.1% | 44.7% | 44.3% | 43.7% | 42.9% | 43.1% | 43.1% |
| FIIs | 7.4% | 8.4% | 8.2% | 8.3% | 7.1% | 7.4% | 8.6% | 7.4% | 7.3% | 8% | 7.7% | 8.4% |
| DIIs | 10.7% | 10.5% | 9.9% | 10% | 11.5% | 11.3% | 10.4% | 7.5% | 7.8% | 7% | 7.7% | 7.4% |
| Public | 35.9% | 34.7% | 35.5% | 35.2% | 35% | 35.2% | 36.3% | 40.8% | 41.1% | 42.1% | 41.6% | 41.1% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 11% |
| No. of Shareholders | 2,58,236 | 2,26,286 | 2,15,796 | 2,04,122 | 1,89,012 | 1,85,436 | 1,85,111 | 1,96,314 | 1,87,039 | 1,90,655 | 1,84,489 | 1,79,373 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Life Insurance Corporation Of India | Public Shareholding | 5.3% | 47,82,452 |
| Rashesh Chandrakant Gogri | Shareholding of Promoter and Promoter Group | 4.2% | 38,34,404 |
| Jaya Chandrakant Gogri | Shareholding of Promoter and Promoter Group | 3.5% | 32,04,310 |
| Anushakti Enterprise Private Limited | Shareholding of Promoter and Promoter Group | 3.3% | 29,92,950 |
| Labdhi Business Trust(saswat Trusteeship Private Limited) | Shareholding of Promoter and Promoter Group | 3.1% | 28,41,504 |
| Hetal Gogri Gala | Shareholding of Promoter and Promoter Group | 3.1% | 28,15,612 |
| Mirik Rajendra Gogri | Shareholding of Promoter and Promoter Group | 3.1% | 27,84,094 |
| Renil Rajendra Gogri | Shareholding of Promoter and Promoter Group | 2.8% | 25,42,750 |
| Sarla Shantilal Shah | Shareholding of Promoter and Promoter Group | 2.7% | 24,35,830 |
| Ntasain Discovery Master Fund | Public Shareholding | 2.3% | 20,67,304 |
| Rajendra Vallabhaji Gogri | Shareholding of Promoter and Promoter Group | 1.6% | 14,25,900 |
| Manomaya Business Trust(alabhya Trusteeship Private Limited) | Shareholding of Promoter and Promoter Group | 1.4% | 13,08,496 |
| Nehal Garewal | Shareholding of Promoter and Promoter Group | 1.2% | 11,22,487 |
| Nishant Pradip Shah | Public Shareholding | 1.1% | 9,97,427 |
| Heena Family Private Trust(barclays Wealth Trustees India Private Limited) | Shareholding of Promoter and Promoter Group | 0.9% | 8,33,859 |
| Safechem Enterprises Private Limited | Shareholding of Promoter and Promoter Group | 0.9% | 8,33,000 |
| Bhavna Family Private Trust(barclays Wealth Trustees India Pvt Ltd) | Shareholding of Promoter and Promoter Group | 0.9% | 8,04,101 |
| Jasmine Family Trust(relacion Trusteeship Services Private Limited) | Shareholding of Promoter and Promoter Group | 0.8% | 6,87,500 |
| Nikhil Parimal Desai | Shareholding of Promoter and Promoter Group | 0.8% | 6,81,754 |
| Alchemie Financial Services Limited | Shareholding of Promoter and Promoter Group | 0.7% | 6,73,006 |
| Lotus Family Trust(gloire Trusteeship Services Private Limited) | Shareholding of Promoter and Promoter Group | 0.7% | 6,24,500 |
| Aarnav Rashesh Gogri | Shareholding of Promoter and Promoter Group | 0.6% | 5,50,000 |
| Aashay Rashesh Gogri | Shareholding of Promoter and Promoter Group | 0.6% | 5,50,000 |
| Manisha Rashesh Gogri | Shareholding of Promoter and Promoter Group | 0.6% | 5,50,000 |
| Arti Rajendra Gogri | Shareholding of Promoter and Promoter Group | 0.5% | 4,55,256 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Rashesh Chandrakant Gogri | 0 | 0% | 2026-03-31 |
| Jaya Chandrakant Gogri | 0 | 0% | 2026-03-31 |
| Hetal Gogri Gala | 0 | 0% | 2026-03-31 |
| Mirik Rajendra Gogri | 27,84,094 | 100% | 2026-03-31 |
| Renil Rajendra Gogri | 15,19,919 | 59.8% | 2026-03-31 |
| Sarla Shantilal Shah | 0 | 0% | 2026-03-31 |
| Rajendra Vallabhaji Gogri | 0 | 0% | 2026-03-31 |
| Nehal Garewal | 0 | 0% | 2026-03-31 |
| Nikhil Parimal Desai | 0 | 0% | 2026-03-31 |
| Aarnav Rashesh Gogri | 0 | 0% | 2026-03-31 |
| Aashay Rashesh Gogri | 0 | 0% | 2026-03-31 |
| Manisha Rashesh Gogri | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Chandrakant V Gogri | Chairman Emeritus | 2025 |
| Rashesh C Gogri | Chairman(Non Exe)&Dir(Non-Ind) | 2025 |
| Hetal Gogri Gala | Vice Chairman / Executive Director / MD | 2025 |
| Narendra Jagannath Salvi | Executive Director & MD | 2025 |
| Rajendra V Gogri | Non-Exec & Non-Independent Dir | 2025 |
| Parimal H Desai | Non-Exec & Non-Independent Dir | 2025 |
| Vinay Gopal Nayak | Independent Non Exe. Director | 2025 |
| Bhavesh R Vora | Independent Non Exe. Director | 2025 |
| Vilas G Gaikar | Independent Non Exe. Director | 2025 |
| Rupal Vora | Independent Non Exe. Director | 2025 |
| Jeenal Savla | Independent Non Exe. Director | 2025 |
| Pradeep Thakur | Independent Non Exe. Director | 2025 |
| NEHAL GAREWAL | Non-Exec & Non-Independent Dir | 2025 |
| Jeevan Mondkar | CS / Compliance Officer / Legal Head | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmacuticals | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Within India | ₹823 Cr | 47.1% |
| Outside India | ₹924 Cr | 52.9% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹5 | 50 | 45 | 45 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2026-02-16 | ₹1.5 (30%) | Interim |
| dividend | 2025-09-15 | ₹2.5 (50%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 5 | 0 | 28 | 13 | 42 | 89 |
| 2025 | 1 | 0 | 28 | 0 | 15 | 43 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
Insider / Designated-Person Trades
30 recent disclosure(s)
Mirik Rajendra GogriDisposal · 9,000
Narendra J SalviDisposal · 3,000
Hetal Gogri GalaAcquisition · 64
Hetal Gogri GalaAcquisition · 63,769
Hetal Gogri GalaAcquisition · 54,276
Hetal Gogri GalaAcquisition · 81,955
Company Information
Incorporated2019
ChairmanRashesh C Gogri
AuditorGokhale & Sathe
Investor Email[email protected] ; investorrelations@aar
📍 Plot No 22/C/1 & 22/C/2, 1st Phase GIDC Vapi, Valsad, Gujarat, 396195
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search